» Articles » PMID: 19136963

Loss of ETHE1, a Mitochondrial Dioxygenase, Causes Fatal Sulfide Toxicity in Ethylmalonic Encephalopathy

Overview
Journal Nat Med
Date 2009 Jan 13
PMID 19136963
Citations 190
Authors
Affiliations
Soon will be listed here.
Abstract

Ethylmalonic encephalopathy is an autosomal recessive, invariably fatal disorder characterized by early-onset encephalopathy, microangiopathy, chronic diarrhea, defective cytochrome c oxidase (COX) in muscle and brain, high concentrations of C4 and C5 acylcarnitines in blood and high excretion of ethylmalonic acid in urine. ETHE1, a gene encoding a beta-lactamase-like, iron-coordinating metalloprotein, is mutated in ethylmalonic encephalopathy. In bacteria, ETHE1-like sequences are in the same operon of, or fused with, orthologs of TST, the gene encoding rhodanese, a sulfurtransferase. In eukaryotes, both ETHE1 and rhodanese are located within the mitochondrial matrix. We created a Ethe1(-/-) mouse that showed the cardinal features of ethylmalonic encephalopathy. We found that thiosulfate was excreted in massive amounts in urine of both Ethe1(-/-) mice and humans with ethylmalonic encephalopathy. High thiosulfate and sulfide concentrations were present in Ethe1(-/-) mouse tissues. Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients. Sulfide is detoxified by a mitochondrial pathway that includes a sulfur dioxygenase. Sulfur dioxygenase activity was absent in Ethe1(-/-) mice, whereas it was markedly increased by ETHE1 overexpression in HeLa cells and Escherichia coli. Therefore, ETHE1 is a mitochondrial sulfur dioxygenase involved in catabolism of sulfide that accumulates to toxic levels in ethylmalonic encephalopathy.

Citing Articles

Engineered mitochondria in diseases: mechanisms, strategies, and applications.

Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.

PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.


Shallow-water mussels (Mytilus galloprovincialis) adapt to deep-sea environment through transcriptomic and metagenomic insights.

Sun L, Liu X, Zhou L, Wang H, Lian C, Zhong Z Commun Biol. 2025; 8(1):46.

PMID: 39806046 PMC: 11729891. DOI: 10.1038/s42003-024-07382-0.


Essential role of sulfide oxidation in brain health and neurological disorders.

Kanemaru E, Ichinose F Pharmacol Ther. 2024; 266:108787.

PMID: 39719173 PMC: 11806942. DOI: 10.1016/j.pharmthera.2024.108787.


Increased ROS levels, antioxidant defense disturbances and bioenergetic disruption induced by thiosulfate administration in the brain of neonatal rats.

Glanzel N, da Rosa-Junior N, Signori M, de Andrade Silveira J, Pinheiro C, Marcuzzo M Metab Brain Dis. 2024; 40(1):73.

PMID: 39704910 DOI: 10.1007/s11011-024-01510-9.


Persulfidation of Human Cystathionine -Lyase Inhibits Its Activity: A Negative Feedback Regulation Mechanism for HS Production.

Jia G, Li H, Gan H, Wang J, Zhu Z, Wang Y Antioxidants (Basel). 2024; 13(11).

PMID: 39594544 PMC: 11591423. DOI: 10.3390/antiox13111402.


References
1.
Gregersen N, Winter V, Corydon M, Corydon T, Rinaldo P, Ribes A . Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C-->T, is present at an unexpectedly high frequency in the general population, as was the case for 625G-->A,.... Hum Mol Genet. 1998; 7(4):619-27. DOI: 10.1093/hmg/7.4.619. View

2.
Szabo C . Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007; 6(11):917-35. DOI: 10.1038/nrd2425. View

3.
Koeberl D, Young S, Gregersen N, Vockley J, Smith W, Benjamin Jr D . Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening. Pediatr Res. 2003; 54(2):219-23. DOI: 10.1203/01.PDR.0000074972.36356.89. View

4.
Psarra A, Sekeris C . Nuclear receptors and other nuclear transcription factors in mitochondria: regulatory molecules in a new environment. Biochim Biophys Acta. 2007; 1783(1):1-11. DOI: 10.1016/j.bbamcr.2007.10.021. View

5.
Moroni I, DIncerti L, Farina L, Rimoldi M, Uziel G . Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria. Neurol Sci. 2000; 21(2):103-8. DOI: 10.1007/s100720070104. View